patients with metastatic breast cancer receiving chemotherapy when administered to target a haemoglobin of 12-14 g/ dl (7.5-8.7 mmol/ l),
kemoteraapiat saavatel metastaatilise rinnavähiga patsientidel, kellele manustatakse ravimit hemoglobiinisisalduse sihtväärtuseni 12... 14 g/ dl (7, 5... 8, 7 mmol/ l),